Clicky

BenevolentAI SA(BAI)

Description: BenevolentAI société anonyme operates as a clinical-stage AI-enabled drug discovery company. The company's BenevolentAI platform powers a pipeline of approximately 20 drug programs. BenevolentAI société anonyme was formerly known as BenevolentAI Limited and changed its name to BenevolentAI société anonyme on April 22, 2022. The company is headquartered in London, United Kingdom.


Keywords: Artificial Intelligence Drug Discovery Société Anonyme S.A. Modern Art

Home Page: www.benevolent.com

4-8 Maple Street
London, W1T 5HD
United Kingdom
Phone: 44 20 3781 9360


Officers

Name Title
Ms. Joanna Shields OBE CEO & Exec. Director
Dr. Ivan Griffin Ph.D. Co-Founder & COO
Dr. Anne Phelan Chief Scientific Officer & Site Head for the Benevolent Cambridge Laboratories
Mr. Nicholas P. Keher Chief Financial Officer
Mr. Daniel Neil Chief Technology Officer
Ms. Fleur Wood VP of Investor Relations
Mr. Will Scrimshaw Gen. Counsel
Ms. Rajin Kang VP of Communications
Ms. Anna Fullerton-Batten Chief People Officer
Mr. Mark Davies Sr. VP of Informatics & Data

Exchange: AS

Country: NL : Netherlands

Currency: Euro (€)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0
Price-to-Sales TTM: 61.5013
IPO Date:
Fiscal Year End: December
Full Time Employees: 350
Back to stocks